From Inspiration to Recognition: ASCO Awards FASCO Title to Gevorg Tamamyan
Gevorg Tamamyan, Co-founder and Editor in Chief of OncoDaily, posted on LinkedIn:
”It is a great honor to be named a Fellow of the American Society of Clinical Oncology (FASCO) – a recognition bestowed upon ASCO members who have shown extraordinary dedication through their voluntary efforts to benefit the Society, the specialty of oncology, and, most importantly, the patients we serve.
Years ago, when I first set foot at ASCO’s Annual Meeting – when all of Chicago was alive with the movement of nearly fifty thousand oncologists and members from around the world – I remember watching, in awe, as the world’s leading experts, whose names I had only read in books, were called to the stage to receive the title of FASCO. I could never have imagined that one day…
What can I say – I am deeply grateful to everyone who, in one way or another, directly or indirectly, has helped make this day possible.
It is, indeed, a great honor – and an even greater responsibility.”
Keep up with Hemostasis Today.
-
Sep 21, 2026, 13:21In His Last UNGA, António Guterres Delivers a Urgent Call for Global Unity
-
Sep 21, 2026, 13:14Fatih Mehmet Gul: Are We Moving Faster Than Our Ability to Ask ‘Should We?’
-
Sep 21, 2026, 13:08Sangita Reddy: How Does Our Own Healthcare Journey in India Look Through the Same Lens?
-
Sep 21, 2026, 12:53Conan McIlwrath: Strengthening Haemophilia Care Through International Collaboration
-
Sep 21, 2026, 12:41Tinatin Muradashvili: Advancing Hemophilia Care Through Education and Collaboration
-
Sep 21, 2026, 12:15Kholoud Al Busaidi: Cold Agglutination and Its Impact on CBC and Blood Grouping Results
-
Sep 21, 2026, 11:03Shaurav Bhattacharyya: Honoring the 2026 Lasker Award Winners
-
Sep 21, 2026, 10:41Jamshid Ullah: Recognizing Blood Disorders Through Laboratory Findings
-
Sep 21, 2026, 10:18Mana Alshehri: A New Step Toward Hemophilia B Gene Therapy in Adolescents